by Clinical Neuropsychologist Online | Monday, December 23, 2024 | Dementia
Abstract US clinical practice guidelines for the diagnostic evaluation of cognitive impairment due to Alzheimer’s Disease (AD) or AD and related dementias (ADRD) are decades old and aimed at specialists. This evidence-based guideline was developed to empower...
by Clinical Neuropsychologist Online | Monday, December 23, 2024 | Neuro Podcasts
This conversation delves into the Boston Cognitive Assessment, a self-administered cognitive test designed to measure various cognitive domains efficiently. The assessment aims to provide valuable information for both patients and healthcare providers, especially in...
by Clinical Neuropsychologist Online | Monday, December 23, 2024 | Neurorehabilitation
Volume 28, Issue 1, January 2025, Page 52-61. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Fateme Tahmasbi Sarvin Sanaie Hanieh Salehi-Pourmehr Salar...
by Clinical Neuropsychologist Online | Monday, December 23, 2024 | Dementia
Abstract INTRODUCTION Psychotropic medication (PM) use in behavioral-variant frontotemporal dementia (bvFTD) is higher than in other dementias. However, no information exists on whether PM use differs between sporadic and genetic bvFTD. METHODS We analyzed data from...
by Clinical Neuropsychologist Online | Monday, December 23, 2024 | Dementia
Abstract INTRODUCTION TOMM40 and APOC1 variants can modulate the APOE-ε4-related Alzheimer’s disease (AD) risk by up to fourfold. We aim to investigate whether the genetic modulation of ε4-related AD risk is reflected in brain morphology. METHODS We tested...
